Vitamin D receptor TaqI and ApaI polymorphisms: A comparative study in patients with Behçet's disease and Rheumatoid arthritis in Tunisian population

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 66-71

  Tizaoui, Kalthoum ^a   Kaabachi, Wajih ^a   Ouled Salah, Marwa ^a   Ben Amor, Amira ^a   Hamzaoui, Agnès ^a,b   Hamzaoui, Kamel ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Beh et's disease; Rheumatoid arthritis; VDR gene polymorphism; Vitamin D

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CASE CONTROL STUDY; CODOMINANCE; CONTROLLED STUDY; DNA POLYMORPHISM; ERYTHEMA NODOSUM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

BEHÇET'S DISEASE; RHEUMATOID ARTHRITIS; VDR GENE POLYMORPHISM; VITAMIN D;

ADULT; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ERYTHEMA NODOSUM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK; TUNISIA; VITAMIN D;

EID: 84901687628     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.05.002     Document Type: Article

References (49)

1. Direskeneli H. Behcet's disease infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 2001, 60:996-1002.
2. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011, 365:2205-2219.
3. Suzuki A., Kochi Y., Okada Y., Yamamoto K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett. 2011, 585:3627-3632.
4. Fei Y., Webb R., Cobb B.L., Direskeneli H., Saruhan-Direskeneli G., Sawalha A.H. Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study. Arthritis Res. Ther. 2009, 11:R66.
5. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Genome-wide pathway analysis of a genome-wide association study on psoriasis and Behcet's disease. Mol. Biol. Rep. 2012, 39:5953-5959.
6. Yazici H., Hatemi G. Empiricism in managing Behçet's syndrome. Clin. Exp. Rheumatol. 2012, 30(3).
7. Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?. Rheumatology 2006, 45:1461-1465.
8. Yazici H., Fresko I. Behçet's disease and other autoinflammatory conditions: what's in a name?. Clin. Exp. Rheumatol. 2005, 23:S1-S2.
9. Hamzaoui K., Hamzaoui A. Immunological responses in patients with Behçet's disease: advances in understanding. Expert Rev. Ophthalmol. 2012, 7(3):261-270.
10. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
11. D'Ambrosio D., Cippitelli M., Cocciolo M.G., et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998, 101:252-262.
12. Rigby W.F., Denome S., Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 1987, 79:1659-1664.
13. Tsoukas C.D., Watry D., Escobar S.S., et al. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J. Clin. Endocrinol. Metab. 1989, 69:127-133.
14. Miyamoto K., Kesterson R.A., Yamamoto H., et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 1997, 11:1165-1179.
15. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
16. Ben-Zvi I., Aranow C., Mackay M., et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010, 5(2):e9193.
17. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 2005, 97:93-101.
18. Kriegel M.A., Manson J.E., Costenbader K.H. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin. Arthritis Rheum. 2011, 40:512-531. e518.
19. Karray E.F., Ben Dhifallah I., Ben Abdelghani K., et al. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet's disease in Tunisians. Joint Bone Spine 2012, 79:144-148.
20. Sweeney C., Curtin K., Murtaugh M.A., Caan B.J., Potter J.D., Slattery M.L. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol. Biomarkers Prev. 2006, 15:744-749.
21. Morrison N.A., Qi J.C., Tokita A., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
22. Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
23. Criteria for diagnosis of Behçet disease. Lancet 1990, 335:1078-1080. International study group for Behçet disease.
24. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
25. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
26. Hamzaoui K., Ben Dhifallah I., Karray E., Elhej Sassi F., Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Behcet's disease. Clin. Exp. Rheumatol. 2010, 28(4 Suppl. 60):S50-S57.
27. Tian Y., Wang C., Ye Z., Xiao X., Kijlstra A., Yang P. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease. Invest. Ophthalmol. Vis. Sci. 2012, 53(10):6434-6441.
28. Melcescu E., Griswold M., Xiang L., Belk S., Montgomery D., Bray M., Del Ben K.S., Uwaifo G.I., Marshall G.D., Koch C.A. Prevalence and cardiometabolic associations of the glucocorticoid receptor gene polymorphisms N363S and BclI in obese and non-obese black and white Mississippians. Hormones 2012, 11(2):166-177.
29. Pani M.A., Knapp M., Donner H., et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000, 49:504-507.
30. Chang T.J., Lei H.H., Yeh J.I., et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin. Endocrinol. 2000, 52:575-580.
31. Cox M.B., Ban M., Bowden N.A., Baker A., Scott R.J., Lechner-Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult. Scler. 2012, 18:16-22.
32. Zhou H., Xu C., Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin. Endocrinol. 2009, 70:938-945.
33. Maalmi H., Sassi F.H., Berraies A., Ammar J., Hamzaoui K., Hamzaoui A. Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: a case control study. Hum. Immunol. 2013, 74:234-240.
34. Cicek M.S., Liu X., Schumacher F.R., Casey G., Witte J.S. Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2549-2552.
35. Li C., Liu Z., Zhang Z., Strom S.S., et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J. Invest. Dermatol. 2007, 127:276-280.
36. Ateş Ö, Dölek B., Dalyan L., Topal-Sarikaya A. Vitamin D receptor gene polymorphisms in rheumatoid arthritis. Turk. J. Rheumatol. 2011, 26:145-149.
37. Maalej A., Petit-Teixeira E., Michou L., Rebai A., Cornelis F., Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun. 2005, 6:707-711.
38. Garcia-Lozano J.R., Gonzalez-Escribano M.F., Valenzuela A., Garcia A., Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 2001, 28:89-93.
39. Bikle D.D. What is new in vitamin D: 2006-2007. Curr. Opin. Rheumatol. 2007, 19(4):383-388.
40. Schauber J., Gallo R.L. The vitamin D pathway: a new target for control of the skin's immune response?. Exp. Dermatol. 2008, 17:633-639.
41. Oda Y., Sihlbom C., Chalkley R.J., et al. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiation. J. Steroid Biochem. Mol. Biol. 2004, 89-90:273-276.
42. Bikle D.D. Vitamin D regulated keratinocyte differentiation. J. Cell. Biochem. 2004, 92:436-444.
43. Do J.E., Kwon S.Y., Park S., Lee E.S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology 2008, 47:840-848.
44. Hirani V., Tull K., Ali A., Mindell J. Urgent action needed to improve vitamin D status among older people in England. Age Ageing 2010, 39:62-68.
45. Lagunova Z., Porojnicu A.C., Lindberg F., Hexeberg S., Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009, 29:3713-3720.
46. Karatay I.S., Yildirim K., Karakuzu A., Kiziltunc A., Engin R.I., Eren Y.B., Aktas A. Vitamin D status in patients with Behcet's disease. Clinics 2011, 66(5):721-723.
47. Kerr G., Sabahi I., Richards J., Caplan L., Cannon G., Reimold A., et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J. Rheumatol. 2011, 38:53-59.
48. Craig S., Yu F., Curtis J., Alarcón G., Conn D., Jonas, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J. Rheumatol. 2010, 37:275-281.
49. Baker J., Baker D., Toedter G., Shults J., Von Feldt J., Leonard B.D. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin. Exp. Rheumatol. 2012, 30:658-664.